Acelyrin Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-268.52	-248.23	-381.64	-64.77	-41.84
Depreciation & Amortization	0.48	0.42	0.12	-	-
Loss (Gain) From Sale of Assets	1.37	-5.63	-	-	-
Asset Writedown & Restructuring Costs	2.92	-	133.06	-	25
Loss (Gain) From Sale of Investments	-14.69	-18.41	-10.5	-0.25	-
Stock-Based Compensation	28.97	44.96	47.32	4.05	0.23
Other Operating Activities	0.6	0.32	-10.14	-0.49	-
Change in Accounts Payable	-0.06	-37.03	34.44	3.78	1.12
Change in Other Net Operating Assets	-36.64	-40.32	17.64	-3.84	10.51
Operating Cash Flow	-285.58	-303.92	-169.71	-61.52	-4.98
Capital Expenditures	-1.19	-1.25	-2.29	-	-
Sale of Property, Plant & Equipment	-	7	-	-	-
Cash Acquisitions	-	-	10.01	-0.08	-
Sale (Purchase) of Intangibles	-	-	-10	-	-25
Investment in Securities	78.49	149.11	-445.46	-47.79	-
Investing Cash Flow	77.3	154.87	-447.74	-47.87	-25
Issuance of Common Stock	4.53	7.33	576.76	-	0.02
Repurchase of Common Stock	-1.94	-1.94	-8.33	-	-
Other Financing Activities	-	-	-	10.29	-
Financing Cash Flow	2.59	5.39	568.44	274.26	124.72
Net Cash Flow	-205.69	-143.66	-49.01	164.87	94.74
Free Cash Flow	-286.77	-305.17	-172	-61.52	-4.98
Free Cash Flow Per Share	-2.87	-3.07	-2.45	-39.50	-7.24
Levered Free Cash Flow	-174.14	-216.69	-250.17	-36.41	-
Unlevered Free Cash Flow	-174.14	-216.69	-250.17	-36.41	-
Change in Net Working Capital	33.31	77.41	-55.39	-2.78	-

Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q